Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (Weighted Average) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $22.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.06% to $22.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $22.5 million, a 1.06% increase, with the full-year FY2024 number at $22.5 million, up 1.06% from a year prior.
  • Shares Outstanding (Weighted Average) was $22.5 million for Q4 2024 at Lemaitre Vascular, up from $22.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $22.5 million in Q4 2024 to a low of $21.2 million in Q4 2021.
  • A 4-year average of $22.0 million and a median of $22.1 million in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 3.87% in 2022, then increased 1.06% in 2024.
  • Lemaitre Vascular's Shares Outstanding (Weighted Average) stood at $21.2 million in 2021, then increased by 3.87% to $22.0 million in 2022, then grew by 1.1% to $22.2 million in 2023, then rose by 1.06% to $22.5 million in 2024.
  • Per Business Quant, the three most recent readings for LMAT's Shares Outstanding (Weighted Average) are $22.5 million (Q4 2024), $22.2 million (Q4 2023), and $22.0 million (Q4 2022).